Remove Biotechnology Remove Healthcare Remove Medical Technology Remove Pharmaceuticals
article thumbnail

Petrie-Flom Welcomes 2022-2023 Student Fellows

Bill Of Health

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. He is deeply interested in the legal issues posed by the rise of artificial intelligence in the healthcare sector, especially as it pertains to intellectual property rights. Louis (USA).

article thumbnail

Governing Health Data for Research, Development, and Innovation: The Missteps of the European Health Data Space Proposal

Bill Of Health

Is research in the interest of the public domain an activity exclusively developed by academic or healthcare entities, or can it be carried out by industry (pharmaceutical, biotechnology, technology companies, medical technology industries, and insurance providers)? If so, how?